申请人:Kissei Pharmaceutical Co., Ltd.
公开号:EP0370760A2
公开(公告)日:1990-05-30
Benzofuro[3,2-c]quinoline compounds of the general formula:
wherein A represents a group of the formula of (̵ CH₂)̵ or -CH₂CH(OH)CH₂-; Y represents an N,N-di-alkylamino group, an N-mono-alkylamino group or a nitrogen atom-containing aliphatic geterocyclic group; n represents 0 or 1; m represents an integer of from 1 to 3, and pharmaceutically acceptable acid addition salts thereof, possess a strong inhibitory action on bone resorption, a stimulatory effect on ossification.
Furthermore, benzofuro[3,2-c]quinoline compounds of the above general formula and pharmaceutically acceptable acid additional salts thereof possess a stimulatory effect on longitudinal bone growth, and thus useful for the prevention or treatment of osteoporosis.
通式如下的苯并呋喃并[3,2-c]喹啉化合物
其中 A 代表 (̵ CH₂)̵ 或 -CH₂CH(OH)CH₂-式中的基团;Y 代表 N,N-二烷基氨基基团、N-单烷基氨基基团或含氮原子的脂族得基环基团;n 代表 0 或 1;m 代表 1 至 3 的整数,及其药学上可接受的酸加成盐,对骨吸收具有强烈的抑制作用,对骨化具有刺激作用。
此外,上述通式的苯并呋喃并[3,2-c]喹啉化合物及其药学上可接受的酸附加盐对纵向骨生长具有刺激作用,因此可用于预防或治疗骨质疏松症。